Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00790569 · ClinicalTrials.gov registry record · NA

Varenicline or Nicotine Patch and Nicotine Gum in Helping Smokers in a Methadone Treatment Program Stop Smoking

A NA study, sponsored by Butler Hospital.

Completed
Registry status
NA
Development phase
315
Enrollment target

NCT00790569 is a NA study that has completed, run by Butler Hospital. The registered enrollment target is 315 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00790569, a NA study, has completed, sponsored by Butler Hospital.

COMPLETED
Registry status
NA
Development phase
315 participants
Enrollment target

Study Summary

RATIONALE: Varenicline, the nicotine patch, and nicotine gum help people stop smoking. It is not yet known whether varenicline is more effective than the nicotine patch given together with nicotine gum in helping smokers quit smoking. PURPOSE: This randomized clinical trial is studying varenicline to see how well it works compared with the nicotine patch given together with nicotine gum in helping smokers in a methadone treatment program stop smoking.

Interventions

  • OTHER placebo
  • DRUG varenicline
  • DRUG nicotine

Trial Details

FieldValue
Enrollment Target 315 participants
Start Date 2008-09
Est. Completion 2012-10
Phase NA

Sponsor

Butler Hospital

103 total trials

What the Registry Record Tells You About NCT00790569

The ClinicalTrials.gov registry entry for NCT00790569 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 315 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Butler Hospital, which has 103 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which placebo is the first listed.

NCT00790569 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00790569 about?

NCT00790569 is a clinical study titled "Varenicline or Nicotine Patch and Nicotine Gum in Helping Smokers in a Methadone Treatment Program Stop Smoking". RATIONALE: Varenicline, the nicotine patch, and nicotine gum help people stop smoking. It is not yet known whether varenicline is more effective than the nicotine patch given together with nicotine gum in helping smokers quit smoking. PURPOSE: This randomized clinical trial is studying varenicline ...

What is the current status of trial NCT00790569?

This trial is currently completed. It is a NA study. The enrollment target is 315 participants. The study started on 2008-09. Estimated completion is 2012-10.

What interventions are being tested in trial NCT00790569?

The interventions under investigation include: placebo (OTHER), varenicline (DRUG), nicotine (DRUG).

Who is sponsoring clinical trial NCT00790569?

This trial is sponsored by Butler Hospital, which has 103 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.